FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2022/12/048248 [Registered on: 19/12/2022] Trial Registered Prospectively
Last Modified On: 14/08/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Medical Device
Surgical/Anesthesia
Other (Specify) [INTRAOCULAR LENS IMPLANTATION]  
Study Design  Other 
Public Title of Study   VISUAL OUTCOME AFTER CATARACT SURGERY 
Scientific Title of Study   REFRACTIVE OUTCOME OF CILIARY SULCUS IMPLANTED INTRAOCULAR LENSES  
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DR LEKSHMY M S 
Designation  JUNIOR RESIDENT 
Affiliation  SRI DEVARAJ URS ACADEMY OF HIGHER EDUCATION AND RESEARCH 
Address  DEPARTMENT OF OPHTHALMOLOGY SRI DEVARAJ URS ACADEMY OF HIGHER EDUCATION AND RESEARCH KOLAR
KOLAR
Kolar
KARNATAKA
563101
India 
Phone  9995281075  
Fax    
Email  lekshmyaravind21@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DR SANGEETHA T 
Designation  ASSOCIATE PROFESSOR 
Affiliation  SRI DEVARAJ URS ACADEMY OF HIGHER EDUCATION AND RESEARCH 
Address  DEPARTMENT OF OPHTHALMOLOGY SRI DEVARAJ URS ACADEMY OF HIGHER EDUCATION AND RESEARCH KOLAR
KOLAR
Kolar
KARNATAKA
563101
India 
Phone  9880031831  
Fax    
Email  sangeetha31jayakumar@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DR SANGEETHA T 
Designation  ASSOCIATE PROFESSOR 
Affiliation  SRI DEVARAJ URS ACADEMY OF HIGHER EDUCATION AND RESEARCH 
Address  DEPARTMENT OF OPHTHALMOLOGY SRI DEVARAJ URS ACADEMY OF HIGHER EDUCATION AND RESEARCH KOLAR
KOLAR
Kolar
KARNATAKA
563101
India 
Phone  9880031831  
Fax    
Email  sangeetha31jayakumar@gmail.com  
 
Source of Monetary or Material Support  
SRI DEVARAJ URS ACADEMY OF HIGHER EDUCATION AND RESEARCH 
 
Primary Sponsor  
Name  SRI DEVARAJ URS ACADEMY OF HIGHER EDUCATION AND RESEARCH 
Address  KOLAR KARNATAKA INDIA 563101 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DR LEKSHMY M S  SRI DEVARAJ URS ACADEMY OF HIGHER EDUCATION   NO: 22, DEPARTMENT OF OPHTHALMOLOGY, FIRST FLOOR, R. L. JALAPPA HOSPITAL & RESEARCH, TAMAKA, KOLAR -563101
Kolar
KARNATAKA 
9995281075
-
lekshmyaravind21@gmail.com 
 
Details of Ethics Committee
Modification(s)  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
SRI DEVARAJ URS MEDICAL COLLEGE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical, (2) ICD-10 Condition: H259||Unspecified age-related cataract,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  CATARACT SURGERY  Routine small incision cataract surgery or phacoemulsification will be performed through a sclerocorneal tunnel. The IOL power will be reduced by 0.5 or 1 D from the IOL power calculated by the SRK-II formula for in-the-bag implantation. The decision to reduce IOL power will be at the discretion of the operating surgeon. Postoperatively patients will be instructed to instill steroid antibiotic eye drops for 6 weeks in a tapering dose and followed up at day 1, day 7 and 1 month for Spherical Equivalent Refraction and complications. 
Comparator Agent  NIL  NIL 
 
Inclusion Criteria  
Age From  40.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  1. Capsule rupture:
a) Anterior capsular tear without extension
b)Anterior capsular tear extending to posterior capsule
c) Posterior capsular tear with intact anterior capsule
2. Zonular dehiscence
3. Weak zonules in case of pseudoexfoliation
4. Uveitis
5. Traumatic subluxation of lens 
 
ExclusionCriteria 
Details  1. Lack of Anterior Capsular Support
2. Patients on any topical IOP-lowering drugs like Timolol.
3. Patients with lacrimal gland and drainage disorder.
4. History of any ocular surface surgery or ocular trauma.
5. Patients with diabetes mellitus.
6. Thyroid disease patients. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To determine the difference in the preoperative predicted and postoperative spherical equivalent refraction for each patient - “Refractive shift”  To determine the difference in the preoperative predicted and postoperative spherical equivalent refraction for each patient at day 1, day 7 and after 1 month postoperatively. 
 
Secondary Outcome  
Outcome  TimePoints 
1. To determine the difference in the IOL power for in the bag implantation and for the IOL implanted in the ciliary sulcus
2. To document any intraoperative and postoperative complications 
One month 
 
Target Sample Size   Total Sample Size="77"
Sample Size from India="77" 
Final Enrollment numbers achieved (Total)= "77"
Final Enrollment numbers achieved (India)="77" 
Phase of Trial   N/A 
Date of First Enrollment (India)   26/12/2022 
Date of Study Completion (India) 20/01/2025 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="1"
Months="4"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details
Modification(s)  
Sent for publication, under review 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary
Modification(s)  

Purpose: Although in-the-bag intraocular lens (IOL) implantation provides the most physiologic positioning and favourable long-term stability, ciliary sulcus placement is preferred in cases of posterior capsule compromise or zonular weakness. This study aims to evaluate differences between predicted and postoperative spherical equivalent refraction, as well as IOL power requirements, in in-the-bag versus ciliary sulcus implantation techniques.

MATERIALS AND METHODS

This prospective interventional study included 77 patients who underwent cataract surgery over the past 18 months. Preoperative visual acuity, axial length, predicted intraocular lens (IOL) power using the SRK/T formula, and predicted refraction were recorded. Postoperative visual acuity and refraction were also assessed. For each patient, the difference between predicted and postoperative refraction for in-the-bag IOL implantation was calculated.

RESULTS

A total of 77 patients (20 males, 57 females) with a mean age of 63.50 ± 10.45 years were included. Mean preoperative and postoperative BCVA improved from 1.039 ± 0.745 to 0.189 ± 0.177 logMAR (P < 0.001). The mean predicted and postoperative spherical equivalent were 0.0108 ± 0.009 and 0.0586 ± 0.177, respectively (P < 0.001). The mean virtual IOL power was 21.50 ± 1.96 D, compared with an implanted IOL power of 22.05 ± 1.94 D (P < 0.001).

CONCLUSION

Ciliary sulcus implantation of IOLs in eyes with posterior capsular defects resulted in significant visual improvement with no major complications. However, differences between predicted and postoperative refraction highlight the need for appropriate IOL power adjustment and careful case selection. Longer-term studies are required to confirm safety and refractive stability.

 
Close